Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 4 to 5 amino acid residues in defined sequence
Reexamination Certificate
2006-04-25
2006-04-25
Campell, Bruce R. (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
4 to 5 amino acid residues in defined sequence
C530S300000
Reexamination Certificate
active
07034109
ABSTRACT:
The invention relates to a sequence of amino acids with the capacity to facilitate transport of an effector across a biological membrane. More specifically, the present invention relates to novelpeptide transporters that specifically target certain cell types for the intracellular delivery of drugs and therapeutic agents.
REFERENCES:
patent: 5597895 (1997-01-01), Gaynor et al.
patent: 5670617 (1997-09-01), Frankel et al.
patent: 5672479 (1997-09-01), Johnson et al.
patent: 5674980 (1997-10-01), Frankel et al.
patent: 5686264 (1997-11-01), Gaynor et al.
patent: 5747641 (1998-05-01), Frankel et al.
patent: 5756684 (1998-05-01), Johnson et al.
patent: 5804604 (1998-09-01), Frankel et al.
patent: 5989814 (1999-11-01), Frankel et al.
patent: 5994108 (1999-11-01), Gaynor et al.
patent: 5994109 (1999-11-01), Woo et al.
patent: 6284456 (2001-09-01), Jones et al.
patent: 6316003 (2001-11-01), Frankel et al.
patent: 6881825 (2005-04-01), Robbins et al.
patent: 2003/0104622 (2003-06-01), Robbins et al.
patent: 2094658 (1993-04-01), None
patent: WO 94/23751 (1994-10-01), None
patent: WO 98/51325 (1998-11-01), None
patent: WO 98/51825 (1998-11-01), None
patent: WO 00/12587 (2000-03-01), None
patent: WO 01/64738 (2001-09-01), None
M.M. Ribeiro, et al. Biochem. Biophys. Res. Comm. (2003) 305, pp. 876-881.
T. Okitsu, et al. Transplant. Proc. (2003) 35, p. 479.
J. Dominguez-Bendala, et al. Diabetes. (2005) 54, pp. 720-726.
Ammendrup, et al. (2000).Diabetes 49: 1468-1476.
Anderson (1989).Clin. Immun. and Immunopathol. 53: S63-S71.
Avrameas, et al. (1998).Proc. Natl. Acad. Sci. USA 95: 5601-5606.
Bleich, et al. (1999).J. Clin. Invest. 103(10): 1431-1436.
Bonner-Weir (1994)Recent Prog. Hormone Res. 49: 91-104.
Bonny, et al. (1998).J. Biol. Chem. 273(4): 1843-1846.
Bonny, et al. (2000).J. Biol. Chem. 275(22); 16466-16472.
Bonny, et al. (2001).Diabetes 50: 77-82.
Breeman, et al. (1999).Int. J. Cancer 81: 658-665.
Brugidou, et al. (1995).Biochem. Biophys. Res. Commun. 214(2): 685-693.
Burns, et al. (1998)J. Biol. Chem. 273(20): 12203-12209.
Cabibbo, et al. (1995).Gene 167: 41-47.
Carithers and Lernerr (1996).Chem. Biol. 3: 537-542.
Chen, et al. (2000).Diabetes 49: 562-570.
Damke (1996).FEBS Letters 389: 48-51.
de Jong, et al. (1999).J. Nucl. Med. 40: 2081-2087.
Dupraz, et al. (1999).Gene Therapy 6: 1160-1169.
Efrat, et al. (1988).Proc. Natl. Acad. Sci. USA 85: 9037-9041.
Flodstrom, et al. (1999).Diabetes 48: 706-713.
Giannoukakis, et al. (1999).Diabetes 48: 1730-1736.
Gibbs (2000).Science 287: 1969-1973.
Gibbs and Oliff (1994).Cell 79: 193-198.
Gotoh, et al. (1987).Transplantation 43(5): 725-730.
Hawiger (1999).Current Opinion Chem. Biol. 3: 89-94.
Hofland, et al. (1999).Proc. Assoc. Am. Physicians 111(1): 63-69.
Hoorens, et al. (1996).J. Clin. Invest. 98(7): 1568-1574.
Ivanenkov, et al. (1999).Biochem. Biophys. Acta 1448: 450-462.
Ivanenkov, et al. (1999).Biochem. Biophys. Acta 1448: 463-472.
Iwahashi, et al. (1996).Diabetologia 39: 530-536.
Iwahashi, et al. (1998).Cytokines, Cell. Mol. Ther. 4: 45-51.
Kato and Sugiyama (1997).Critical Rev. Thera. Drug Carr. Systems 14(3) 287-331.
Kim, et al. (2000).Anticancer Res. 20: 439-444.
Larsen, et al. (1998).J. Biol. Chem. 273(24): 15294-15300.
Lin, et al. (1995).J. Biol. Chem. 270(24): 14255-14258.
Lund, et al. (1990).J. Biol. Chem. 265(25): 15713-15723.
Mahato, et al. (1997).Critical Rev. There. Drug Carr. Systems 14(2): 133-172.
Mahato, et al. (1997).J. Drug Targeting 4(6): 337-357.
Mandrup-Poulsen (1996).Diabetologia 39: 1005-1029.
Mandrup-Poulsen (1998).BMJ 316: 1221-1225.
Mauricio and Mandrup-Poulsen, Apoptosis and the Pathogenesis of IDDM: A Question of Life and Death,Diabetes, 47: 1537-1543 (1998).
Mukherjee, et al. (1997).Physiol. Rev. 77(3): 759-803.
Negri, et al. (2000).Genomics 64: 324-330.
Nerup, et al. (1988).Diabetes Care 11(supp. 1): 16-23.
Oehike, et al. (1998).Biochem. Biophys. Acta 1414: 127-139.
Offord, et al. (1997).Meth. Enzymol. 287: 348-369.
Pasqualini and Ruoslahti (1996).Mol. Psychiatry 1: 423.
Pasquallini and Ruoslahti (1996).Nature 380: 364-366.
Peralta, et al. (1990).Endocrinol. 127(2): 595-603.
Rabinovitch, et al. (1999).Diabetes 48: 1223-1229.
Renschler, et al (1994).Proc. Natl. Acad. Sci. USA 91: 3623-3627.
Roitt (1991).Essential Immunology.Chapter 4: 65-83.
Rose and Vizzavona (1999)J. Am. Chem. Soc. 121: 7034-7038.
Rothbard, et al. (2000).Nature Med. 6(11): 1253-1257.
Rouquet, et al. (1996).Curr. Biol 6(9): 1192-1195.
Scharfmann and Czemichow (1996).Diabetes and Metabolism 22: 223-228.
Schwarze, et al. (1999).Science 285: 1569-1572.
Scott and Smith (1990).Science 249: 386-390.
Sela and Zisman (1997).FASEB J. 11: 449-456.
Sjoholm (1998).Cell Death Diff. 5: 461-468.
Smith and Jarett (1988).Laboratory Invest. 58(6): 613-629.
Smith and Scott (1993).Meth. Enzymol. 217: 228-257.
Stephens, et al. (1997).J. Autoimmunity 10: 293-298.
Stephens, et al. (1999).Endocrinol. 140(7): 3219-3227.
Suzuki, et al. (2002).J. Biol Chem. 277(4): 2437-2443.
Terskikh, et al. (1997).Proc. Natl. Acad. Sci. USA 94: 1663-1668.
Thorens (1992).Proc. Natl. Acad. Sci. USA 89: 8641-8645.
Torgerson, et al. (1998).J. Immunology 161: 6084-6092.
Ulbrich, et al. (2000).J. Controlled Rel. 64: 63-79.
Usami, et al. (1998).Biochem Pharmacol. 55: 185-191.
Volz, et al. (1995)FEBS Letters 373: 23-29.
Wang, et al. (1999).Endocrinol. 140(3): 1200-1204.
Welsh, et al. (1999).Mol. Med. 5: 169-180.
Widmann, et al. (1995).Biochem J. 315: 203-214.
Yamada, et al. (1999).Diabetes 48: 478-483.
Yamato, et al. (1997).Horn. Metab. Res. 29: 56-59.
Yoon, et al. (1999).Science 284: 1183-1187.
York, et al. (1999).J. Biol Chem. 274(2): 1164-1171.
Zacher, et al. (1980).Gene 9: 127-140.
Zeng, et al. (1996).J. Peptide Sci. 2: 66-72.
Zwick, et al. (1998).Curr. Opin. Biotech. 9: 427-436.
International Search Report for PCT/IB03/03097, mailed Sep. 30, 2004.
Campell Bruce R.
Elrifi Ivor R.
Kosar Andrew D.
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Intracellular delivery of biological effectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular delivery of biological effectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular delivery of biological effectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3592390